32
Participants
Start Date
October 22, 2025
Primary Completion Date
January 19, 2027
Study Completion Date
January 19, 2027
BMS-986504
Specified dose on specified days
Local Institution - 0001, Beijing
Local Institution - 0006, Harbin
Local Institution - 0007, Jinan
Local Institution - 0012, Tianjin
Local Institution - 0002, Fuzhou
Local Institution - 0011, Xinxiang
Local Institution - 0010, Guangzhou
Local Institution - 0009, Shenzhen
Local Institution - 0003, Yokohama-shi, Asahi-ku
Local Institution - 0004, Koto-ku
Local Institution - 0005, Chūōku
Local Institution - 0008, Sunto-gun
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY